TransMedics Grants 71,815 Stock Options, 47,924 RSUs to Nine Employees

By Public Technologies
  • TransMedics granted nine employees non-qualified stock options covering 71,815 shares and 47,924 restricted stock units on October 28, 2026.
  • Chief Financial Officer Fernando Araujo received options covering 34,419 shares and 22,969 restricted stock units.
  • The 10-year options vest 25% on employees' first employment anniversaries, with the remainder vesting monthly over the subsequent three years.
  • Restricted stock units vest 25% on each of the first four employment anniversaries; all vesting requires continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transmedics Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610301605PR_NEWS_USPR_____NE85931) on October 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.